RxSight Inc. (RXST) has projected its fourth quarter 2024 revenue to reach approximately $40.2 million, marking a 41% increase compared to the same period the previous year.
For the full year 2025, RxSight foresees revenue to be between $185.0 million and $197.0 million, which equates to a growth rate of 32% to 41% from 2024.
The company also predicts a gross profit margin of 71% to 73% for 2025. Furthermore, RxSight anticipates its operating expenses for the year to fall within the $165.0 million to $170.0 million range, factoring in non-cash stock-based compensation costs estimated at $22.0 million to $25.0 million.
